A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain)

References

• Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269.
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967–1976.
   PubMed Web of Science ®Google Scholar
• Alm E, Broberg EK, Connor T, et al. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European region, January to June 2020. Euro Surveill. 2020;25(32):2001410.
   PubMedGoogle Scholar
• González-Candelas F, Shaw M-A, Phan T, et al. One year into the pandemic: short-term evolution of SARS-CoV-2 and emergence of new lineages. Infect Genet Evol. 2021;92:104869.
   PubMed Web of Science ®Google Scholar
• Rambaut A, Holmes EC, O’Toole Á, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5(11):1403–1407.
   PubMed Web of Science ®Google Scholar
• Coronavirus disease (COVID-19) advice for the public. 2020.
   Google Scholar
• Real Decreto 463/2020. E stado de alarma para la gestión de la situación de crisis sanitaria ocasionada por el COVID-19. March 14 2020. Available at: https://boe.es/buscar/act.php?id=BOE-A-2020-3692.
   Google Scholar
• El Gobierno aprueba un plan de desescalada que se prolongará hasta finales de junio. 2020. Available at: https://www.lamoncloa.gob.es/consejodeministros/resumenes/Paginas/2020/280420-consejo_ministros.aspx.
   Google Scholar
• Case definition for coronavirus disease 2019 (COVID-19), as of 3 December 2020. Available at: https://www.ecdc.europa.eu/en/covid-19/surveillance/case-definition: European Centre for Disease Prevention and Control (ECDC).
   Google Scholar
• Bioinformatics: Minimum coverage required. Artic Network: Available at:https://community.artic.network/t/minimum-coverage-required/49.
   Google Scholar
• Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731–2739.
   PubMed Web of Science ®Google Scholar
• Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID's innovative contribution to global health. Glob Chall. 2017;1(1):33–46.
   PubMedGoogle Scholar
• Novel coronavirus (2019-nCoV) - situation report. 30 January 2020, Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2: World Health Organisation (WHO).
   Google Scholar
• Rawaf S, Allen LN, Stigler FL, et al. Lessons on the COVID-19 pandemic, for and by primary care professionals worldwide. Eur J Genet Pract. 2020;26(1):129–133.
   PubMed Web of Science ®Google Scholar
• Pollán M, Pérez-Gómez B, Pastor-Barriuso R, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396(10250):535–544.
   PubMed Web of Science ®Google Scholar
• Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959–9981.
   PubMedGoogle Scholar
• Volz E, Mishra S, Chand M, et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 2021;593(7858):266–269.
   PubMed Web of Science ®Google Scholar
• Vigilancia COVID-19 en España. Informes semanales COVID-19. (2020). Available at: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/-CO VID-19.-Informes-previos.aspx: Insituto Carlos III (ISCIII).
   Google Scholar
• Rifa E, Andrés Antón CA, Blanco I, et al. Analysis and prediction of COVID-19 for European Union and other countries: report #251. July 2021. Available at: https://biocomsc.upc.edu/en/shared/20210702_report_251.pdf.
   Google Scholar
• Hadfield J, Megill C, Bell SM, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34(23):4121–4123.
   PubMed Web of Science ®Google Scholar
• Alteri C, Cento V, Piralla A, et al. Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy. Nat Commun. 2021;12(1):434.
   PubMed Web of Science ®Google Scholar
• Rambaut A LN, Pybus O, Barclay W, et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. December 2020: Available at: https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563.
   Google Scholar
• Alpert T, Brito AF, Lasek-Nesselquist E, et al. Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States. Cell. 2021;184(10):2595–2604.e13.
   PubMed Web of Science ®Google Scholar
• Hodcroft EB, Zuber M, Nadeau S, et al. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021;595(7869):707–712.
   Google Scholar
• Mallon PWG, Crispie F, et al. Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemic. medRxiv. 2021: 29.
   Google Scholar
• Di Giallonardo F, Puglia I, Curini V, et al. Emergence and spread of SARS-CoV-2 lineages B.1.1.7 and P.1 in Italy. Viruses. 2021;13(5):794.
   PubMed Web of Science ®Google Scholar
• Díez-Fuertes F, Iglesias-Caballero M, García-Pérez J, et al. A founder effect led early SARS-CoV-2 transmission in Spain. J Virol. 2021;95(3):e01583-20.
   PubMed Web of Science ®Google Scholar
• Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–827.e19.
   PubMed Web of Science ®Google Scholar
• Callaway E. The coronavirus is mutating - does it matter? Nature. 2020;585(7824):174–177.
   PubMed Web of Science ®Google Scholar
• Cella E, et al. SARS-CoV-2 lineages and Sub-lineages circulating worldwide: a dynamic overview. Chemotherapy. 2021;66(1-2):3–7.
   PubMed Web of Science ®Google Scholar
• Guthrie JL, Sandra Zittermann ST, Chen Y, et al. Detection of the novel SARS-CoV-2 European lineage B.1.177 in Ontario, Canada. J Clin Virol Plus. 2021;1:4.
   Google Scholar
• Soriano V, de Mendoza C, Gómez-Gallego F, et al. Third wave of COVID-19 in Madrid, Spain. Int J Infect Dis. 2021;107:212–214.
   PubMed Web of Science ®Google Scholar
• Funk T, Pharris A, Spiteri G, et al. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021. Euro Surveill. 2021;26(16):2100348.
   PubMedGoogle Scholar
• Akkiz H. Implications of the novel mutations in the SARS-CoV-2 genome for transmission, disease severity, and the vaccine development. Front Med (Lausanne). 2021;8:636532.
   PubMed Web of Science ®Google Scholar
• Frampton D, Rampling T, Cross A, et al. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect Dis. 2021;21(9):1246–1256.
   PubMed Web of Science ®Google Scholar
• Rifa E, Andrés Antón CA, Blanco I, et al. Analysis and prediction of COVID-19 for European Union and other countries: report #248. June 2021. Available at: https://www.dropbox.com/s/9tn6638v4j1ax1 g/20210625_Report_248.pdf?dl=0.
   Google Scholar
• Implications for the EU/EEA on the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern. 23 June 2021, European Centre for Disease Prevention and Control: Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Implications-for-the-EU-EEA-on-the-spread-of-SARS-CoV-2-Delta-VOC-23-June-2021_2.pdf.
   Google Scholar
• Teng S, Sobitan A, Rhoades R, et al. Corrigendum to: Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity. Brief Bioinform. 2021:22(5);bbab176.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li Q, Nie J, et al. Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants. Signal Transduct Target Ther. 2021;6(1):196.
   PubMed Web of Science ®Google Scholar
• Eckerle LD, Becker MM, Halpin RA, et al. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 2010;6(5):e1000896.
   PubMed Web of Science ®Google Scholar
• Ramanathan M, Ferguson ID, Miao W, et al. SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. Lancet Infect. 2021;21(8):1070.
   Google Scholar
• Xie X, Liu Y, Liu J, et al. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484 K and N501Y variants by BNT162b2 vaccine-elicited sera. Nat Med. 2021;27(4):620–621.
   PubMed Web of Science ®Google Scholar
• Singh J, Rahman SA, Ehtesham, et al. SARS-CoV-2 variants of concern are emerging in India. Nat Med. 2021;27(7):1131–1133.
   Google Scholar
• Wang R, Chen J, Gao K, et al. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries. Genomics. 2021;113(4):2158–2170.
   PubMed Web of Science ®Google Scholar
• Li Q, Wu J, Nie J, et al. The impact of mutations in SARS-CoV-2 Spike on viral infectivity and antigenicity. Cell. 2020;182(5):1284–1294.e9.
   PubMed Web of Science ®Google Scholar
• Lubinski B, Frazier LE, Phan M, et al. Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda. bioRxiv. 2021.06.30.450632.
   PubMedGoogle Scholar